Otsuka, Lundbeck Seek Alzheimer's Agitation Claim For Antipsychotic

 
• By Lucie Ellis-Taitt
  
Neurology
Otsuka, Lundbeck target third indication for Rexulti in Alzheimer's disease

More from Clinical Trials

More from R&D